ArticleEye (London, England)2025

A viewpoint about Lenadogene nolparvovec failing to meet its primary endpoint even though it permanently corrects the m.11778G>A mutation causative of LHON.

Isabella Panfoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.